Simpler alternative to CARCINOscreen(®) based on quantitative PCR (qPCR)

Area of Science:

• Toxicology and Environmental Health
• Molecular Biology
• Biotechnology

Background:

• Chemical carcinogenicity poses a significant human health risk.
• The existing microarray-based CARCINOscreen system predicts hepatocarcinogenicity with high accuracy but requires specialized expertise.
• There is a need for more accessible and cost-effective methods for assessing chemical carcinogenicity.

Purpose of the Study:

• To develop a quantitative PCR (qPCR)-based system as an alternative to the microarray-based CARCINOscreen.
• To identify a predictive gene set for assessing chemical hepatocarcinogenicity.
• To evaluate the accuracy and feasibility of the qPCR-based system.

Main Methods:

• Screened 3,150 candidate gene sets for predictive potential.
• Selected an optimized four-gene set (Abcb1b, Eprs, Map3K8, Igh-6) for the qPCR assay.
• Validated the qPCR-based system using training and validation trials in rats.

Main Results:

• The optimized four-gene set accurately predicted hepatocarcinogenicity in rats.
• The qPCR-based CARCINOscreen achieved prediction accuracies of 82.8%-86.4%.
• The gene Abcb1b showed a potential link to chemical carcinogenicity.

Conclusions:

• The qPCR-based CARCINOscreen is a promising, user-friendly, and cost-efficient tool for primary health hazard assessment.
• This method provides a viable alternative to microarray-based systems for predicting chemical carcinogenicity.
• The study highlights the potential of Abcb1b as a biomarker for chemical carcinogenicity.